Articles from Amanat Acquisition Corp

BERKELEY HEIGHTS, N.J. and WESTFIELD, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Corxel Pharmaceuticals, Inc. (“Corxel US”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for obesity and related cardiometabolic conditions, and Amanat Acquisition Corp (Nasdaq: AMAN) (“Amanat”), a publicly traded special purpose acquisition company, today announced they have entered into a definitive business combination agreement.

WESTFIELD, N.J., May 19, 2026 (GLOBE NEWSWIRE) -- Amanat Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 7,500,000 Class A ordinary shares at an offering price of $10.00 per share. The Class A ordinary shares are expected to trade on the Nasdaq Capital Market under the ticker symbol “AMAN” beginning today. The offering is expected to close on May 20, 2026, subject to customary closing conditions.